Potential Therapies of COVID-19 Drug - A Review
Keywords:COVID-19, COVID-19 medicine, Covaxin, Covishield, Plasma therapy, Treatment of COVID-19.
Coronavirus disease 2019 or novel coronavirus 2019 is referred as COVID-19. SARS-CoV-2 is the virus that causes the infection(severe acute respiratory syndrome coronavirus 2). Since the need for vaccine was critical, the government and private sector invested significantly more money in its growth. A questionnaire was distributed among people of different occupations within India and other countries to study the awareness of people on the potential therapies of COVID-19. The questionnaire was sent to 205 people and 201 responses were obtained and 4 were ignored. The study was made to analyze how many people are aware of the COVID-19 and its vaccines. We also studied and reviewed the potential therapies in COVID-19.
How to Cite
Copyright (c) 2022 Sakshi Singh, Navneet Khurana, Ramandeep Kaur, Suraj Bhardwaj, Himani Mehta, Neha Sharma
This work is licensed under a Creative Commons Attribution 4.0 International License.
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.